SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-001660
Filing Date
2024-01-08
Accepted
2024-01-08 07:35:25
Documents
19
Period of Report
2024-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 60435
2 ex4-1.htm EX-4.1 124774
3 ex4-2.htm EX-4.2 124399
4 ex10-1.htm EX-10.1 351941
5 ex10-2.htm EX-10.2 296321
6 ex99-1.htm EX-99.1 13046
7 ex99-1_001.jpg GRAPHIC 3852
8 ex4-1_001.jpg GRAPHIC 3244
  Complete submission text file 0001493152-24-001660.txt   1312886

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abeo-20240108.xsd EX-101.SCH 3045
10 XBRL LABEL FILE abeo-20240108_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE abeo-20240108_pre.xml EX-101.PRE 22379
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3311
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 24518348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)